Gene · 406966
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Non-destructive and efficient method for obtaining miRNA information in cells by artificial extracellular vesicles. | Sci Rep | 2023 | 38097629 | PubTator, text mining | PubMed |
| Changes in miRNA expression in the lungs of pigs supplemented with different levels and forms of vitamin D. | Mol Biol Rep | 2023 | 38085380 | PubTator, text mining | PubMed |
| Integrated analysis of the potential roles of microRNA-messenger RNA networks in prostate adenocarcinoma. | Heliyon | 2023 | 38076048 | PubTator, text mining | PubMed |
| MiRNAs in Alcohol-Related Liver Diseases and Hepatocellular Carcinoma: A Step toward New Therapeutic Approaches? | Cancers (Basel) | 2023 | 38067261 | PubTator, text mining | PubMed |
| Circulating endothelial extracellular vesicle signatures correspond with ICU requirement: an exploratory study in COVID-19 patients. | Intensive Care Med Exp | 2023 | 38032394 | PubTator, text mining | PubMed |
| Novel pyroptosis-related lncRNAs and ceRNAs predict osteosarcoma prognosis and indicate immune microenvironment signatures. | Heliyon | 2023 | 38027935 | PubTator, text mining | PubMed |
| Optimized RT-qPCR and a novel normalization method for validating circulating miRNA biomarkers in ageing-related diseases. | Sci Rep | 2023 | 38012217 | PubTator, text mining | PubMed |
| Lung Inflammation Signature in Post-COVID-19 TB Patients. | Int J Mol Sci | 2023 | 38003504 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cells in the Pathogenesis and Therapy of Autoimmune and Autoinflammatory Diseases. | Int J Mol Sci | 2023 | 38003230 | PubTator, text mining | PubMed |
| The Role of Long Noncoding RNAs in Intestinal Health and Diseases: A Focus on the Intestinal Barrier. | Biomolecules | 2023 | 38002356 | PubTator, text mining | PubMed |
| miRNA Expression Patterns in Early- and Late-Stage Prostate Cancer Patients: High-Throughput Analysis. | Biomedicines | 2023 | 38002073 | PubTator, text mining | PubMed |
| MicroRNAs as Molecular Biomarkers for the Characterization of Basal-like Breast Tumor Subtype. | Biomedicines | 2023 | 38002007 | PubTator, text mining | PubMed |
| microRNA-184 in the landscape of human malignancies: a review to roles and clinical significance. | Cell Death Discov | 2023 | 38001121 | PubTator, text mining | PubMed |
| Small molecule regulators of microRNAs identified by high-throughput screen coupled with high-throughput sequencing. | Nat Commun | 2023 | 37989753 | PubTator, text mining | PubMed |
| Recent advances on high-efficiency of microRNAs in different types of lung cancer: a comprehensive review. | Cancer Cell Int | 2023 | 37986065 | PubTator, text mining | PubMed |
| In silico analysis of prognostic and diagnostic significance of target genes from prostate cancer cell lines derived exomicroRNAs. | Cancer Cell Int | 2023 | 37978493 | PubTator, text mining | PubMed |
| The Arising Role of Extracellular Vesicles in Cholangiocarcinoma: A Rundown of the Current Knowledge Regarding Diagnostic and Therapeutic Approaches. | Int J Mol Sci | 2023 | 37958547 | PubTator, text mining | PubMed |
| Identification of serum miR-1246 and miR-150-5p as novel diagnostic biomarkers for high-grade serous ovarian cancer. | Sci Rep | 2023 | 37935712 | PubTator, text mining | PubMed |
| Identification of stably expressed microRNAs in plasma from high-grade serous ovarian carcinoma and benign tumor patients. | Mol Biol Rep | 2023 | 37934368 | PubTator, text mining | PubMed |
| Screening microRNAs as potential prognostic biomarkers for lung adenocarcinoma. | Ann Med | 2023 | 37930873 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406966/papers?page=6